Robust data also support the absence of interference of MenACWY-CRM coadministration with immune responses to MMR, varicella, HPV, typhoid fever ... is the need to test multiple hypotheses ...

HPV is a leading cause of cervical cancer in women, but 50% of people who develop the cancer are never tested. A self-collection test could help.

The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of ...

India has launched two HPV test kits as a step forward in combating cervical cancer, the second most common type of cancer ...

Aotearoa New Zealand has embraced self-tests for cervical screening with a University of Otago–Ōtākou Whakaihu Waka-led study ...

Menopause marks the end of a woman’s childbearing years, but it doesn’t mark the end of the need for a particular screening ...

Bicara Therapeutics shows potential to reshape cancer care with ficerafusp alfa and robust funding post-IPO. Find out why ...

NavDx+Gyn is a cell-free DNA-based fragmentomic profiling assay that enhances the detection and monitoring of human papillomavirus (HPV)-driven gynecologic cancers. Leveraging the robust ...

The newly validated HPV Test kits use a chip-based real-time PCR (RT-PCR) technique, which is known for its accuracy and speed.